Claro Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,480
Closed -$517K 379
2023
Q2
$517K Buy
5,480
+31
+0.6% +$2.69K 0.13% 190
2023
Q1
$451K Buy
5,449
+20
+0.4% +$1.57K 0.13% 193
2022
Q4
$405K Sell
5,429
-1,011
-16% -$77.9K 0.13% 194
2022
Q3
$612K Hold
6,440
0.24% 105
2022
Q2
$612K Buy
+6,440
New +$667K 0.24% 105
2022
Q1
Sell
-6,401
Closed -$829K 286
2021
Q4
$829K Hold
6,401
0.3% 87
2021
Q3
$725K Buy
6,401
+9
+0.1% +$1.03K 0.3% 84
2021
Q2
$662K Buy
6,392
+20
+0.3% +$1.89K 0.3% 91
2021
Q1
$533K Buy
6,372
+66
+1% +$5.58K 0.27% 106
2020
Q4
$575K Hold
6,306
0.31% 91
2020
Q3
$503K Hold
6,306
0.32% 91
2020
Q2
$436K Sell
6,306
-30
-0.5% -$2.13K 0.3% 99
2020
Q1
$398K Buy
6,336
+45
+0.7% +$3.25K 0.37% 84
2019
Q4
$489K Hold
6,291
0.38% 79
2019
Q3
$461K Hold
6,291
0.41% 71
2019
Q2
$387K Sell
6,291
-45
-0.7% -$2.72K 0.36% 85
2019
Q1
$404K Buy
6,336
+51
+0.8% +$2.91K 0.4% 76
2018
Q4
$365K Buy
+6,285
New +$318K 0.29% 81

Other funds holding EW

Claro Advisors's EW Position: Q3 2023 in Review

Claro Advisors sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 5,480 shares — an estimated $517K sold.

Claro Advisors first reported a position in EW in Q4 2018 and held it in 18 quarters. The position peaked at $829K in Q4 2021. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Claro Advisors reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Claro Advisors sold 5,480 Edwards Lifesciences shares in Q3 2023, an estimated $517K.
  • Claro Advisors first reported a position in Edwards Lifesciences in Q4 2018 and held it in 18 quarters.
  • Claro Advisors's Edwards Lifesciences position peaked at $829K in Q4 2021.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Claro Advisors's 13F filing for Q3 2023, filed 10 Oct 2023.